Guardant Health (GH) Net Equity Issued and Repurchased (2018 - 2023)

Guardant Health (GH) posted Net Equity Issued and Repurchased of $90.6 million for Q4 2023, down 64.33% sequentially from $254.0 million in Q4 2018.

Guardant Health (GH) Net Equity Issued and Repurchased (2018 - 2023) Analysis & Trends

Guardant Health has reported Net Equity Issued and Repurchased for 2 years, with the latest figure at $90.6 million in Q4 2023.

Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $90.6 million in Q4 2023, while the trailing twelve-month figure through Dec 2024 was $90.6 million (changed 0.0% YoY) and the FY2025 annual result came in at $257.1 million, changed N/A from the prior year.
Net Equity Issued and Repurchased slipped to $90.6 million in Q4 2023 per GH's latest filing, from $254.0 million in the prior quarter.
Over five years, Net Equity Issued and Repurchased peaked at $90.6 million in Q4 2023 and troughed at $90.6 million in Q4 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Equity Issued (Qtr)
1	Thermo Fisher Scientific	234.15 Bn	230.09 Bn	8.34 Bn	-
2	Danaher	152.10 Bn	147.75 Bn	3.61 Bn	-
3	Natera	48.48 Bn	47.38 Bn	486.15 Mn	-
4	Agilent Technologies	44.35 Bn	42.55 Bn	990.00 Mn	-
5	Iqvia Holdings	43.68 Bn	41.60 Bn	1.44 Bn	-
6	Idexx Laboratories	43.02 Bn	42.83 Bn	779.09 Mn	-
7	Illumina	34.39 Bn	33.22 Bn	770.00 Mn	-
8	Mettler Toledo International	28.29 Bn	28.24 Bn	650.22 Mn	-
9	Labcorp Holdings	27.51 Bn	27.37 Bn	1.11 Bn	-
10	Guardant Health	22.38 Bn	21.33 Bn	219.03 Mn	-

Download Data